[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100478726":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":43,"collaborators":45,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":57,"maxAge":10,"enrollmentInfo":58,"targetDuration":10,"studyType":61,"phases":10,"briefSummary":62,"conditions":63,"keywords":65,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"The Christie NHS Foundation Trust","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"All patients",null,"Colorectal cancer patients",[13],"Other: Retrospective tissue sample analysis",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Retrospective tissue sample analysis","Archival formalin-fixed, paraffin-embedded (FFPE) tumour tissue from colorectal cancer peritoneal metastasis and paired primary tumours, where available - taken as standard care",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Richa Garvia, Ms","CONTACT","0161 446 3000","removed_due_to_spam@email.com",[26],{"facility":27,"status":28,"city":29,"state":10,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Christie Hospital NHS Foundation Trust","RECRUITING","Manchester","M20 4BX","United Kingdom","UK",{"type":34,"coordinates":35},"Point",[36,37],-2.23743,53.48095,{"lat":37,"lon":36},[40],{"name":41,"role":22,"phone":42,"phoneExt":10,"email":24},"Richa Garvia","01614463000",{"type":44,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[46],{"name":47,"class":6},"University of Manchester","100478726","molecular-characterisation-of-colorectal-cancer-peritoneal-metastases-100478726",false,"NCT05513716","Molecular Characterisation of Colorectal Cancer Peritoneal Metastases","Molecular Characterisation of Colorectal Cancer Peritoneal Metastases: Genomic and Transcriptomic Analysis With Correlation of Clinical Outcomes","COLOMET II","Participants are eligible to be included in the study only if all of the following criteria apply:\n\n1. Patients ≥ 18 years old who have been diagnosed with colorectal cancer and have colorectal peritoneal metastases,\n2. have had cytoreductive surgery at the Christie\n3. have availability of archival tumour tissue (paired CRC and CRPM)\n\nExclusion Criteria:\n\n* None","ALL","18 Years",{"count":59,"type":60},200,"ESTIMATED","OBSERVATIONAL","This project aims to characterise the tumour cell and tumour microenvironment of colorectal cancer peritoneal metastases, understand molecular changes leading to colorectal peritoneal metastasis, identify potential biomarkers and novel treatment strategies.",[64],"Colorectal Cancer Metastatic",[66],"Colorectal Cancer Peritoneal Metastatic","2024-12-31",{"date":69,"type":70},"2025-01-01","ACTUAL",{"date":72,"type":70},"2024-02-04",{"date":74,"type":60},"2025-07-03",{"name":5,"class":6},1]